Bonnie E Brett, Bruno K Koko, Habib O Y Doumbia, Frédéric Kouadio Koffi, Savorgnan E Assa, Kollet Y A S Zahé, Hortense Faye-Ketté, Séraphin Kati-Coulibaly, Remco Kort, Wilbert Sybesma, Gregor Reid, Carolina de Weerth
Journal: Psychoneuroendocrinology 2022;129():105255
PMID: 34020263
This semi-randomized controlled trial examined the effects of a probiotic food supplement on cortisol and C-reactive protein (CRP) in a sample of 262 four-to seven-year-old children (56% girls) in two economically-disadvantaged schools in an urban setting in Côte d'Ivoire. For one semester, children in one school were randomized to receive a probiotic (N = 79) or placebo (N = 85) fermented dairy food each day they attended school; one child (due to medical reasons) and all children in the other school (N = 98) continued their diets as usual. Children provided two saliva samples at 11:30 on consecutive days at the end of the study. Analyses revealed that the probiotic group had lower cortisol than the placebo or diet-as-usual groups (p = .015); CRP levels were comparable across groups (p = .549). Exploratory analyses suggested that dose and regularity of consumption may impact the biomarkers as well. This study provides the first evidence that a probiotic milk product may lower cortisol in a sample of young, economically-disadvantaged children.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Full Text Sources:
Other Literature Sources:
Miscellaneous:
Research Materials:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.